Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates
This quarterly report represents an earnings surprise of 23.19%. A quarter ago, it was expected that this company would post a loss of $0.27 per share when it actually produced a loss of $0.30, delivering a surprise of -11.11%.
Over the last four quarters, the company has surpassed consensus EPS estimates just once.
Quanterix , which belongs to the Zacks Medical - Products industry, posted revenues of $30.33 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 8.99%. This compares to year-ago revenues of $32.07 million. The company has topped consensus revenue estimates three times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Quanterix shares have lost about 50.3% since the beginning of the year versus the S&P 500's decline of -3.8%.
While Quanterix has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Quanterix: unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.38 on $30.83 million in revenues for the coming quarter and -$1.62 on $138.32 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Products is currently in the bottom 33% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, Medtronic (MDT), is yet to report results for the quarter ended April 2025. The results are expected to be released on May 21.
This medical device company is expected to post quarterly earnings of $1.58 per share in its upcoming report, which represents a year-over-year change of +8.2%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Medtronic's revenues are expected to be $8.81 billion, up 2.6% from the year-ago quarter.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Quanterix Corporation (QTRX) : Free Stock Analysis Report
Medtronic PLC (MDT) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Why UnitedHealth Stock Is Skyrocketing Today (Hint: Warren Buffett)
Key Points Berkshire Hathaway's latest SEC filing revealed that the company has taken a $1.6 billion stake in UnitedHealth Group. Berkshire added a few others while reducing stakes in both Apple and Bank of America. UnitedHealth has faced several challenges this year, including the revelation of multiple DOJ investigations and the resignation of its CEO. 10 stocks we like better than UnitedHealth Group › Shares of UnitedHealth Group (NYSE: UNH) are jumping on Friday, up 13.8% as of 2:14 p.m. ET. The spike comes as the S&P 500 (SNPINDEX: ^GSPC) declined 0.1% and the Nasdaq Composite (NASDAQINDEX: ^IXIC) fell 0.3%. The troubled health insurance giant is finally seeing its stock rebound after months of trouble, thanks to the purchase of 5 million shares by Warren Buffett's Berkshire Hathaway. Berkshire buys UNH Berkshire Hathaway's latest regulatory filing revealed that the company took a considerable stake in UnitedHealth. The 5 million-share, $1.6 billion stake makes the massive health insurer the 18th-biggest position in Berkshire's portfolio. Buffett's company also trimmed its positions in Apple and Bank of America. The move took Wall Street by surprise, given the many issues UnitedHealth faces, and the revelation sent shares soaring immediately. UnitedHealth is struggling The company's most recent quarterly report revealed a darkening financial picture, including a significant miss on earnings per share, as costs from medical care continue to balloon. The company was also forced to suspend guidance as it tries to adapt to the shifting market. Its financial woes are far from the company's only issues, having recently suffered the sudden departure of its CEO for "personal reasons." The departure comes as the company faces two Department of Justice (DOJ) probes -- one criminal and one civil -- into its Medicare billing practices. Buyer beware It's hard to disagree with the Oracle of Omaha, but there are just too many issues facing UnitedHealth at the moment and with no clear picture of an imminent turnaround. I would stay away from the stock. Should you invest $1,000 in UnitedHealth Group right now? Before you buy stock in UnitedHealth Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and UnitedHealth Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $663,630!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,115,695!* Now, it's worth noting Stock Advisor's total average return is 1,071% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025 Bank of America is an advertising partner of Motley Fool Money. Johnny Rice has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Apple and Berkshire Hathaway. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy. Why UnitedHealth Stock Is Skyrocketing Today (Hint: Warren Buffett) was originally published by The Motley Fool
The Hill
24 minutes ago
- The Hill
Bessent makes first visit to IRS as acting commissioner
Treasury Secretary Scott Bessent made his first visit to the Internal Revenue Service (IRS) as the acting commissioner on Thursday, days after President Trump ousted Billy Long from the position. Bessent, who is now the tax agency's seventh commissioner, met with the leadership during which he discussed the modernization of the IT systems within the IRS, a Treasury Department spokesperson told The Hill. During the visit, the interim chief also emphasized his priorities for the agency: 'Collections, Customer Service and Privacy.' IRS whistleblowers Gary Shapley and Joseph Ziegler were also in attendance alongside Bessent, the spokesperson added. Their visit was first reported by The New York Post. Shapley and Ziegler, who were promoted to leadership positions at the Treasury Department in March, alleged that the Department of Justice slow-walked its probe into Hunter Biden, the son of former President Biden. The IRS did not respond to a request for comment. Long, a controversial pick to lead the IRS, was removed as the commissioner last week after just two months in the role. The ouster came as Treasury Department leadership clashed with Long and there were concerns within the administration that the former House lawmaker (R-Mo.) was not a good fit to lead the IRS. After his removal last week, Long said on social media that it was an 'honor' to serve his 'friend' Trump and that he will be nominated for as an ambassador to Iceland. 'I am thrilled to answer his call to service and deeply committed to advancing his bold agenda,' Long wrote online last Friday. 'Exciting times ahead!'
CNBC
25 minutes ago
- CNBC
Fed policy will be the major focus next week for a market that's trying to broaden out
Whatever is the future path of monetary policy could decide what happens next for a stock market that's struggling to broaden out and extend leadership beyond the companies that have worked so far in 2025. Central bank officials from around the globe will convene next week in Jackson Hole, Wyoming for the Federal Reserve's annual economic symposium , an event that will be closely watched for any clues from Fed Chair Jerome Powell as to what will happen at its remaining policy meetings this year, in September, October and December. This week, the prospect of more interest rate cuts — potentially even a supersized half point next month — drove up parts of the market that have been left behind. The Russell 2000 rallied more than 3%, headed for its best week since May, when some technical analysts had anticipated a small cap summer. The equal weight S & P 500 outperformed. Health care, this year's laggard, was the best-performing S & P 500 sector , climbing almost 5% this week. So long as rate cuts are coming — without a a slowing economy or rise in inflation — the reversal in fortunes for the market's former laggards may continue. That would be a boon for an overvalued market that has again depended on a handful of its biggest winners for this year's gains. "Will small-, mid-caps outperform large caps? That's the question," said Brian Leonard, portfolio manager at Keeley Gabelli Funds. "We think there's a possibility they do." Potentially, Fed Chair Powell could throw cold water on the market if he takes a more hawkish stance than expected at Jackson Hole next week, especially as macroeconomic concerns persist. But many market observers are certain that the typically staid Fed chief will do his best not to show his cards. Leonard, for one, said he's cautiously optimistic on the broader equity market. On Friday, the major averages were each headed for a winning week, with the Dow Jones Industrial Average higher by nearly 2% and the S & P 500 and Nasdaq Composite each up roughly 1%. Future of the Fed The Fed will come under the spotlight next week at a critical time. The Trump administration is actively searching for the next Fed chief to succeed Powell when his term ends next May, a race that is raising questions about Fed independence. This week, it was revealed there are 11 potential candidates , including Jefferies Chief Market Strategist David Zervos, former Fed Governor Larry Lindsey and BlackRock chief investment officer for global fixed income Rick Rieder. Many of the candidates, including Zervos and Rieder, have publicly called for aggressive interest rate cuts. It's a likely prerequisite for President Donald Trump, whose rising hostility toward Powell has hinged on the Fed having yet to lower interest rates this year. Trump has unleashed a barrage of barbs, calling Powell — who Trump nominated as Fed chair in late 2017 — "TOO LATE," and "stupid," among other epithets. Yet, economists expect that Powell is more likely to use his time on the podium in Wyoming to address how monetary policy could change in the years ahead. He's scheduled to speak at 10 a.m. ET next Friday, Aug. 22. This week, Sarah House, senior economist at Wells Fargo Economics, wrote that the Fed will likely outline an approach that abandons a policy of allowing inflation to sometimes run a little above 2% to make up for periods when inflation was lower than 2%, and instead target "a simple 2% inflation target, where it does not try to make up for past misses." Other changes could include tying its maximum employment objective more directly to its inflation goal, House said. "We'll find out what Mr. Powell says next week at the Jackson Hole symposium — if there is a likelihood of a cut or not, and we'll see what his commentary is," Leonard, the portfolio manager, said. Fed minutes next week could also illustrate the current dynamic at the central bank, given that the last meeting had two policymakers dissenting from the group and voting in favor of lower interest rates. It was the most meaningful dissent since late 1993. Caution and optimism The stock market continues to perform extraordinarily well this year, defiant of macroeconomic and geopolitical concerns. Yet, with August and September both months that show seasonally weaker prices, and investors continuing to scan for signs of the tariff impact on business, Wall Street is bracing for continued, near-term choppiness. Next week Target and Walmart report earnings results. The big box retailers are likely to provide crucial commentary on the state of consumer spending during the critical back-to-school season. Week ahead calendar All times ET. *2025 Federal Reserve Bank of Kansas City's Economic Policy Symposium in Jackson Hole, Wyoming on "Labor Markets in Transition: Demographics, Productivity, and Macroeconomic Policy" takes place Aug. 21-23 Monday, Aug. 18 10:00 a.m. NAHB Housing Market Index (August) Earnings: Palo Alto Networks Tuesday, Aug. 19 8:30 a.m. Building Permits preliminary (July) 8:30 a.m. Housing Starts (July) Earnings: Keysight Technologies , Jack Henry & Associates , Home Depot Wednesday, Aug. 20 2:00 p.m. FOMC Minutes Earnings: TJX , Analog Devices , Estee Lauder Companies , Target , Lowe's Companies Thursday, Aug. 21 8:30 a.m. Continuing Jobless Claims (08/09) 8:30 a.m. Initial Claims (08/16) 8:30 a.m. Philadelphia Fed Index (August) 9:45 a.m. PMI Composite preliminary (August) 9:45 a.m. S & P PMI Manufacturing preliminary (August) 9:45 a.m. S & P PMI Services preliminary (August) 10:00 a.m. Existing Home Sales (July) 10:00 a.m. Leading Indicators (July) Earnings: Workday , Ross Stores , Intuit , Walmart Friday, Aug. 22
